Published in Transl Med (Sunnyvale) on August 30, 2016
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27
Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med (2013) 20.98
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (1996) 18.47
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (1996) 16.92
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature (1995) 15.15
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature (1999) 13.73
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature (2003) 12.10
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature (1995) 9.84
Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood (1998) 7.70
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation (2003) 7.40
Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science (2001) 7.13
Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet (2002) 7.11
Vascular endothelial growth factor and angiogenesis. Pharmacol Rev (2004) 5.41
Nitric oxide synthases: regulation and function. Eur Heart J (2011) 4.71
American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc (2004) 4.48
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation (2003) 4.43
The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell (1993) 4.33
MicroRNA-34a regulates cardiac ageing and function. Nature (2013) 4.03
Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem (1996) 3.57
Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation (1996) 3.28
Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation (2004) 3.26
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol (2006) 3.25
Hutchinson-Gilford progeria syndrome: review of the phenotype. Am J Med Genet A (2006) 3.09
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol (2006) 2.97
NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal (2006) 2.95
Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood (2004) 2.76
Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation (2004) 2.73
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol (2006) 2.57
PDGF signalling controls age-dependent proliferation in pancreatic β-cells. Nature (2011) 2.53
Endothelial aging. Cardiovasc Res (2005) 2.46
Vascular cell senescence: contribution to atherosclerosis. Circ Res (2007) 2.32
Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A (2006) 2.28
Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol (2002) 2.23
Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition. Am J Physiol Heart Circ Physiol (2006) 2.19
Gender differences in coronary heart disease. Neth Heart J (2010) 2.16
Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res (2012) 2.14
Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation (1999) 2.14
Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes (2007) 2.12
The critical role of metabolic pathways in aging. Diabetes (2012) 2.12
Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol (2007) 2.11
The FGF system has a key role in regulating vascular integrity. J Clin Invest (2008) 2.09
Invited review: aging and the cardiovascular system. J Appl Physiol (1985) (2003) 2.08
Role of TNF-alpha in vascular dysfunction. Clin Sci (Lond) (2009) 2.06
Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy. Circ Res (2005) 2.05
Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol (2007) 2.05
Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A (2012) 2.04
Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging. Am J Pathol (2007) 2.02
A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. Proc Natl Acad Sci U S A (2008) 2.02
MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res (2011) 2.01
Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol (2009) 2.01
Doxorubicin cardiomyopathy. Cardiology (2009) 1.99
Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Exp Gerontol (2005) 1.96
Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation (2011) 1.88
miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc Natl Acad Sci U S A (2010) 1.81
HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res (2003) 1.76
Proinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging. Physiol Genomics (2004) 1.73
Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol (2000) 1.72
Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. J Biol Chem (1995) 1.71
Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol (2008) 1.69
Exercise effect on weight and body fat in men and women. Obesity (Silver Spring) (2007) 1.68
Cardiovascular effects of exercise: role of endothelial shear stress. J Am Coll Cardiol (1996) 1.66
Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol Med (2012) 1.66
Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin Exp Immunol (2000) 1.61
MicroRNAs and their roles in aging. J Cell Sci (2012) 1.60
MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun (2010) 1.58
Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes. Diabetes (2002) 1.58
Conversion of blood androgens to estrogens in normal adult men and women. J Clin Invest (1969) 1.56
Spatial and temporal dynamics of the endothelium. J Thromb Haemost (2005) 1.51
Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine. Circulation (2003) 1.51
Exercise and the nitric oxide vasodilator system. Sports Med (2003) 1.48
Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation (2006) 1.44
Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes (1997) 1.44
Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation (2002) 1.43
Testosterone relaxes rabbit coronary arteries and aorta. Circulation (1995) 1.42
Regular exercise, hormone replacement therapy and the age-related decline in carotid arterial compliance in healthy women. Cardiovasc Res (2003) 1.41
Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J Biol Chem (2003) 1.41
Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol (1996) 1.37
Impact of farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome. Circulation (2014) 1.37
Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care (2011) 1.35
Mechanisms of cardiovascular disease in accelerated aging syndromes. Circ Res (2007) 1.34
Vascular microRNAs. Curr Drug Targets (2010) 1.34
Testosterone: a vascular hormone in health and disease. J Endocrinol (2013) 1.32
miRNA response to DNA damage. Trends Biochem Sci (2011) 1.32
Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management. Nutr Metab Cardiovasc Dis (2009) 1.31
Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. Am J Med (1981) 1.30
Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res (2000) 1.29
Blood pressure and ageing. Postgrad Med J (2007) 1.29
Molecular bases of progeroid syndromes. Hum Mol Genet (2006) 1.27
Is endothelium the origin of endothelial progenitor cells? Arterioscler Thromb Vasc Biol (2010) 1.27
Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation. Aging Cell (2009) 1.26
Physiology of the endothelium. Br J Anaesth (2004) 1.25
Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1. Circ Res (2008) 1.24
Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease. Arterioscler Thromb Vasc Biol (2006) 1.18
Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Curr Opin Hematol (2009) 1.17
The effect of physical exercise on endothelial function. Sports Med (2009) 1.15
Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem Biophys Res Commun (1993) 1.13
Telomere length in Hutchinson-Gilford progeria syndrome. Mech Ageing Dev (2009) 1.10
A proposal linking clearance of circulating lipoproteins to tissue metabolic activity as a basis for understanding atherogenesis. Circ Res (1980) 1.10
Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering. Antioxid Redox Signal (2014) 1.08